CClinicalTrials.gg
Status unknownNCT04153825Updated Nov 6, 2019

Comparison of Effectiveness of Two Different Electrotherapy Agents on Central Sensitization

An interventional study of Transcutaneous Electrical Nerve Stimulation and Interferential Current in Osteoarthritis, Knee, sponsored by Turkish League Against Rheumatism. Status unknown at 1 site in Turkey. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-11-06.

Sponsored by Turkish League Against Rheumatism · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2019), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Feb 2019, registered Oct 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Study summary

The aim of this study is to compare the efficacy of transcutaneous electrical nerve stimulation (TENS), interferential currents (IFCs) and sham devices in improving central sensitization (CS) findings, including pressure pain thresholds, pain catastrophizing, depression, and kinesiophobia in patients with knee osteoarthritis (OA).

Read the detailed description

Knee OA, which is the most frequently encountered type of OA is a leading cause of disability and chronic pain. CS is as important as nociceptive component in the pathogenesis of OA-related pain. Therefore, the necessary interventions for CS should be also considered when deciding the treatment protocol.TENS and IFC have been safely and commonly employed in the conservative treatment of knee OA. However, there are limited and inconsistent data concerning the impact of these modalities on CS component of pain.Therefore, the aim of this study is to investigate whether these agents are effective on CS and they are superior to each other.

02

Conditions studied

  • Osteoarthritis, Knee

Keywords

  • Physical therapy modalities
  • Osteoarthritis knee
  • Central nervous system sensitization
  • Pain
  • Electric Stimulation Therapy
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's planned enrollment of 80 is above the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

Turkish League Against Rheumatism is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

40 to 75 years of age, Having bilateral knee OA radiologically with a Kellgren-Lawrence grade of 2 or 3.

Reporting knee pain of more than 3 on the visual analog scale (VAS) over the last 6 months Being unfamiliar with TENS and IFC use

Exclusion criteria

-

Exclusion Criteria:

  1. Having the history of any contraindication for electrotherapy (pacemakers, epilepsy, dermatological conditions, abnormal sensation in the knees, pregnancy),
  2. Having a knee surgery or intra-articular corticosteroid or hyaluronic acid injection within 6 months.
  3. Taking any drugs acting on the nervous system such as anticonvulsants, antidepressants, myorelaxants, or opioid drugs in the study period.
  4. Having fibromyalgia, inflammatory rheumatologic, severe psychological disorders -
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Active TENS Group

    Ten sessions of active conventional TENS and hydrocollator hot-pack.

    Device: Transcutaneous Electrical Nerve Stimulation · Other: Hydrocollator hot-pack

  • Active comparator
    Active IFC Group

    Ten sessions of active interferential current and hydrocollator hot-pack.

    Device: Interferential Current · Other: Hydrocollator hot-pack

  • Sham comparator
    Sham TENS Group

    Ten sessions of sham TENS and hydrocollator hot-pack.

    Other: Hydrocollator hot-pack · Device: Sham transcutaneous Electrical Nerve Stimulation

  • Sham comparator
    Sham IFC Group

    Ten sessions of sham IFC and hydrocollator hot-pack.

    Other: Hydrocollator hot-pack · Device: Sham interferential Current

Interventions

  • DeviceTranscutaneous Electrical Nerve Stimulation

    Electrodes are placed around painful regions determined by the patient as patients are in the sitting position with the knees extended. The device is set at pulse duration of 50 to 80 μs; pulse frequency of 50 to 100 Hz; low-intensity (paraesthesia, not painful). The patient wears TENS for a 20-minute duration for each knee.

    Also known as: TENS

  • DeviceInterferential Current

    Electrodes are placed diagonally around the painful areas defined by the patient, with the patient in the sitting position with the knees extended. The device is set at carrier frequency 4000 Hz, amplitude modulated frequency (AMF) 100 Hz, scanning frequency 50 Hz, scanning mode 1: 1 s. The patient wears ICF for a 20-minute duration for each knee.

    Also known as: IFC

  • OtherHydrocollator hot-pack

    The hot-pack (at a surface temperature of almost 42 °C) is administered on knees while patients are in sitting position with the knees extended. Every session includes 20 minutes of hot-pack for each knee.

  • DeviceSham transcutaneous Electrical Nerve Stimulation

    Electrodes are placed around painful regions determined by the patient as patients are in the sitting position with the knees extended.TENS unit in place but not turned on.The patient wears TENS for a 20-minute duration for each knee.

    Also known as: Sham TENS

  • DeviceSham interferential Current

    Electrodes are placed diagonally around the painful areas defined by the patient, with the patient in the sitting position with the knees extended. IFC unit in place but not turned on.The patient wears ICF for a 20-minute duration for each knee.

    Also known as: Sham IFC

06

What researchers measure

Primary outcomes

  1. Pressure-pain thresholds

    Pressure pain thresholds is measured on the knee (M. Vastus Medialis) and on the upper part of the homolateral arm (lateral part of M. Deltoideus, 10 cm below acromion) using a pressure algometer. The pressure is raised at a rate of almost 1 kg/s, until the patient first notifies that the pressure sensation changes to a pain sensation.

    Time frame: Change from baseline pressure-pain thresholds at 2 weeks and at 12 weeks

  2. Tampa Scale of Kinesiophobia

    Tampa Scale contains 17 parts that measure anxiety and fear related to movement. The total score ranges between 17-68 points. Higher scores represent higher grades of kinesiophobia.

    Time frame: Change from baseline kinesiophobia scores at 2 weeks and at 12 weeks

  3. Beck Depression Inventory (BDI)

    Beck Depression Inventory is a 21-item questionnaire that examines the characteristic symptoms of depression.

    Time frame: Change from baseline BDI scores at 2 weeks and at 12 weeks.

  4. Pain catastrophizing scale (PCS)

    PCS consists of 13 items in three subscales (rumination, helplessness, and magnification). Higher final score indicates more catastrophic thinking related to pain.

    Time frame: Change from baseline PCS scores at 2 weeks and at 12 weeks.

Secondary outcomes

  1. Age

    years

    Time frame: Baseline

  2. Gender

    female/male

    Time frame: Baseline

  3. Height

    centimeter (cm)

    Time frame: Baseline

  4. Weight

    kilogram (kg)

    Time frame: Baseline

  5. Comorbidity

    self reported

    Time frame: Baseline

  6. Visual analogue scale (VAS)

    VAS ranging levels from 0 (no pain) to 10 (maximal pain).

    Time frame: Change from baseline, at 2 weeks and at 12 weeks

  7. Western Ontario and McMaster University (WOMAC) Index.

    There are three subscales with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a total WOMAC score. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.

    Time frame: Change from baseline, at 2 weeks and at 12 weeks

  8. Timed Up and Go Test (TUG)

    Timed up and go test is used to assess mobility which recorded the time of rising from a back-rest chair, walking at a normal pace 3 meters, turning, walking back to the chair, and sitting recumbently. In one minute durations, each participant will perform the test three times and this time will be recorded in seconds.

    Time frame: Change from baseline, at 2 weeks and at 12 weeks

  9. Five Times Sit to Stand Test

    The participant is asked to sit-to-stand action from a standard chair five times as quickly as possible, and the time taken to complete is recorded.

    Time frame: Change from baseline, at 2 weeks and at 12 weeks

07

Study locations

1 of 1 sites recruiting
  • Ankara City Hospital
    Ankara, Turkey
    • Şahide E Almaz, MD · Contact · edartuc@gmail.com · +905534488730
    • Hatice Bodur · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All the collected data will be shared with investigators of the study.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 6, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04153825
Lead sponsor
Turkish League Against Rheumatism
Responsible party
Şahide Eda Almaz (Principal Investigator, MD, Turkish League Against Rheumatism) — Principal investigator
First posted
Nov 6, 2019
Start date
Feb 1, 2019
Primary completion
Feb 1, 2020 (estimated)
Completion
Feb 1, 2020 (estimated)
Last update
Nov 6, 2019

Study contacts

Şahide E Almaz, MD
Contact
edartuc@gmail.com
+905534488730
Hatice Bodur, Professor
Contact
haticebodur@gmail.com
+905054848496
Şahide E Almaz, MD
principal investigator · Turkish League Against Rheumatism
Hatice Bodur, Professor
study director · Turkish League Against Rheumatism
Aslı Çalışkan Uçkun, MD
study chair · Turkish League Against Rheumatism
Filiz Acar Sivas, Professor
study chair · Turkish League Against Rheumatism
Fatma G Yurdakul, MD
study chair · Turkish League Against Rheumatism

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion